Frédéric Baron

13.6k total citations · 1 hit paper
220 papers, 7.2k citations indexed

About

Frédéric Baron is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Frédéric Baron has authored 220 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Hematology, 73 papers in Immunology and 41 papers in Genetics. Recurrent topics in Frédéric Baron's work include Hematopoietic Stem Cell Transplantation (151 papers), Acute Myeloid Leukemia Research (63 papers) and Immune Cell Function and Interaction (50 papers). Frédéric Baron is often cited by papers focused on Hematopoietic Stem Cell Transplantation (151 papers), Acute Myeloid Leukemia Research (63 papers) and Immune Cell Function and Interaction (50 papers). Frédéric Baron collaborates with scholars based in Belgium, United States and France. Frédéric Baron's co-authors include Rainer Storb, Brenda M. Sandmaier, David G. Maloney, Michael B. Maris, Mohamed L. Sorror, Barry E. Storer, Yves Béguin, Arnon Nagler, Mohamad Mohty and Georges Fillet and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Frédéric Baron

210 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

2005 2.0k citations Mohamed L. Sorror, Rainer Storb et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Baron Belgium	40	5.2k	1.9k	1.7k	1.4k	1.4k	220	7.2k
Madan Jagasia United States	43	5.1k 1.0×	1.9k 1.0×	1.6k 1.0×	1.6k 1.1×	1.3k 0.9×	251	7.2k
Daniel R. Couriel United States	45	4.7k 0.9×	1.9k 1.0×	1.8k 1.1×	1.1k 0.8×	895 0.6×	155	6.6k
Yoshiko Atsuta Japan	42	5.1k 1.0×	1.7k 0.9×	1.6k 0.9×	1.8k 1.2×	881 0.6×	451	6.6k
Dietrich W. Beelen Germany	45	5.2k 1.0×	2.0k 1.0×	1.5k 0.9×	1.4k 1.0×	1.4k 1.0×	322	7.4k
Claudio G. Brunstein United States	44	5.9k 1.1×	3.1k 1.6×	2.3k 1.4×	1.3k 0.9×	1.8k 1.3×	247	8.0k
Kai‐Yan Liu China	46	6.5k 1.3×	2.5k 1.3×	2.2k 1.3×	2.0k 1.4×	1.1k 0.8×	478	8.6k
Judith Marsh United Kingdom	52	6.6k 1.3×	2.7k 1.4×	1.8k 1.1×	713 0.5×	2.0k 1.4×	210	9.1k
Benedetto Bruno Italy	51	5.5k 1.1×	2.1k 1.1×	2.6k 1.6×	1.0k 0.7×	1.3k 0.9×	278	8.0k
Annalisa Ruggeri France	38	3.3k 0.6×	1.3k 0.7×	1.5k 0.9×	888 0.6×	1.0k 0.7×	207	5.6k
Kirk R. Schultz Canada	45	5.0k 1.0×	1.8k 0.9×	1.3k 0.8×	2.6k 1.8×	1.1k 0.8×	214	7.4k

Countries citing papers authored by Frédéric Baron

Since Specialization

Citations

This map shows the geographic impact of Frédéric Baron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Baron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Baron more than expected).

Fields of papers citing papers by Frédéric Baron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Baron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Baron. The network helps show where Frédéric Baron may publish in the future.

Co-authorship network of co-authors of Frédéric Baron

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Baron. A scholar is included among the top collaborators of Frédéric Baron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Baron. Frédéric Baron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bazarbachi, Ali, Jacques‐Emmanuel Galimard, Gérard Socié, et al.. (2025). Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP. American Journal of Hematology. 100(8). 1374–1386.

Baron, Frédéric, Myriam Labopin, Jurjen Versluis, et al.. (2024). Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American Journal of Hematology. 99(12). 2296–2305.

Baron, Frédéric, Annalisa Ruggeri, Christophe Peczynski, et al.. (2023). Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. 58(8). 936–941. 1 indexed citations

Baron, Frédéric, Kevin K. Ariën, Delphine Kemlin, et al.. (2022). Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Frontiers in Immunology. 13. 827242–827242. 5 indexed citations

Voeght, Adrien De, Évelyne Willems, Sophie Servais, et al.. (2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers. 14(17). 4266–4266. 1 indexed citations

Dubois, Sophie, Sophie Servais, Stéphanie Humblet‐Baron, et al.. (2021). Mechanisms of GVHD Prevention By PTCy in Humanized Mice. Transplantation and Cellular Therapy. 27(3). S253–S254. 1 indexed citations

Dubois, Sophie, Laurence Seidel, Jo Caers, et al.. (2021). Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplantation. 56(11). 2672–2681. 20 indexed citations

Velden, Walter J. F. M. van der, Joop H. Jansen, Brigitte Bär, et al.. (2021). Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 56(8). 1964–1970. 7 indexed citations

Baron, Frédéric, Myriam Labopin, Annalisa Ruggeri, et al.. (2019). Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT. Blood Cancer Journal. 9(4). 15 indexed citations

10.

Baron, Frédéric, Jacques‐Emmanuel Galimard, Myriam Labopin, et al.. (2019). Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin. Haematologica. 105(4). 1138–1146. 19 indexed citations

11.

Shouval, Roni, Annalisa Ruggeri, Myriam Labopin, et al.. (2017). An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia. Clinical Cancer Research. 23(21). 6478–6486. 25 indexed citations

12.

Heusschen, Roy, Joséphine Muller, Nadia Withofs, et al.. (2017). Multiple myeloma bone disease: from mechanisms to next generation therapy. Open Repository and Bibliography (University of Liège). 1 indexed citations

13.

Göktuna, Serkan İsmail, Kateryna Shostak, Tieu‐Lan Chau, et al.. (2016). The Prosurvival IKK-Related Kinase IKKϵ Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine. Cancer Research. 76(9). 2587–2599. 19 indexed citations

14.

Servais, Sophie, Céline Grégoire, Frédéric Baron, et al.. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Open Repository and Bibliography (University of Liège). 7. 1 indexed citations

15.

Hannon, Muriel, Yves Béguin, Grégory Ehx, et al.. (2015). Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning. Clinical Cancer Research. 21(14). 3131–3139. 24 indexed citations

16.

Hannon, Muriel, Stéphanie Humblet‐Baron, Carlos Graux, et al.. (2012). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Haematologica. 97. 1 indexed citations

17.

Castermans, Emilie, Muriel Hannon, Pierre Drion, et al.. (2009). Reconstitution du système immunitaire après allogreffe de cellules souches hématopoïétiques.. RMLG. Revue médicale de Liège. 64. 2–8.

18.

Diaconescu, Razvan, Marie-Térèse Little, Wendy M. Leisenring, et al.. (2005). What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?. Biology of Blood and Marrow Transplantation. 11(5). 335–344. 10 indexed citations

19.

Baron, Frédéric, Étienne Baudoux, Pascale Frère, et al.. (2002). Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or CD34-Selected Peripheral Blood Stem Cells. Journal of Hematotherapy & Stem Cell Research. 11(2). 301–314. 17 indexed citations

20.

Baron, Frédéric & Yves Béguin. (2002). Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Hematotherapy & Stem Cell Research. 11(2). 243–263. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact